Targeting sympathetic glia for treating cardiovascular diseases

Area of Science:

• Neuroscience
• Cardiovascular Biology
• Glial Cell Biology

Background:

• Gq G protein-coupled receptor (Gq-GPCR) signaling in glial fibrillary acidic protein-expressing (GFAP⁺) glia is crucial for central nervous system (CNS) neuron-glia interactions.
• The role of Gq-GPCR signaling in peripheral GFAP⁺ glia, specifically satellite glial cells (SGCs) in sympathetic ganglia, is an emerging area of research.
• SGCs are implicated in modulating sympathetic nerve activity (SNA) and its impact on physiological and pathological processes.

Purpose of the Study:

• To investigate the role of Gq-GPCR signaling in satellite glial cells (SGCs) of sympathetic ganglia.
• To explore the modulation of sympathetic-regulated cardiac functions by SGCs.
• To present a novel experimental approach for manipulating SGC signaling in sympathetic ganglia.

Main Methods:

• Utilized adeno-associated virus (AAV) vectors for targeted manipulation of satellite glial cell signaling.
• Investigated the functional impact of Gq-GPCR activation in SGCs on cardiac function.
• Assessed the modulation of sympathetic nerve activity (SNA) by SGCs.

Main Results:

• Demonstrated that Gq-GPCR activation in SGCs positively modulates sympathetic-regulated cardiac functions.
• Showcased successful targeted viral transduction in ganglionic SGCs using AAV.
• Established the significance of SGCs in regulating sympathetic nerve activity (SNA).

Conclusions:

• Satellite glial cells (SGCs) play a significant role in modulating cardiac function through Gq-GPCR signaling.
• Targeting sympathetic glia, particularly SGCs, presents a promising therapeutic strategy for cardiovascular diseases (CVDs).
• The developed AAV-mediated gene delivery system offers a powerful tool for future research into sympathetic ganglia function.